LabCorp Backs Resolution Bioscience’s Liquid Biopsy Test for NSCLC
XTalks
SEPTEMBER 28, 2020
The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The panel of genes in the test only include known NSCLC-associated genes, making the test specific to the disease. Personalized Approach.
105 
Let's personalize your content